Screening for novel HDAC-inhibitors targeting epigenetically dysregulated cell differentiation in triple-negative breast cancer

被引:0
|
作者
Kulik, A. [1 ]
Esser, K. [1 ]
Niederacher, D. [1 ]
Neubauer, H. [1 ]
Kurz, T. [2 ]
Fehm, T. [1 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Dept Obstet & Gynecol, Life Sci Ctr, Dusseldorf, Germany
[2] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Duseldorf, Germany
关键词
D O I
10.1055/s-0040-1714584
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
74
引用
收藏
页码:E44 / E44
页数:1
相关论文
共 50 条
  • [1] Targeting dysregulated cell differentiation in triple-negative breast cancer - an innovative approach using novel HDAC-inhibitors
    Esser, K.
    Kulik, A.
    Niederacher, D.
    Neubauer, H.
    Kurz, T.
    Fehm, T.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E96 - E96
  • [2] Novel STAT3 & HDAC inhibitors that selectively target triple-negative breast cancer cell
    Wu, Bocheng
    CANCER RESEARCH, 2019, 79 (13)
  • [3] LAPATINIB SENSITIZES TRIPLE-NEGATIVE BREAST CANCER CELLS TO HDAC INHIBITORS
    Chen, Y-J.
    Chien, P-H.
    Huang, W-C.
    ANNALS OF ONCOLOGY, 2012, 23 : 34 - 34
  • [4] Identification of Novel HDAC-Inhibitors Targeting Epigenetic Dysregulations in MDA-MB-231 Cell Differentiation
    Esser, Knud
    Kulik, Andrea
    Niederacher, Dieter
    Neubauer, Hans
    Kurz, Thomas
    Fehm, Tanja
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 136 - 136
  • [5] Targeting triple-negative breast cancer
    Kirkpatrick, Peter
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) : 21 - 21
  • [6] Targeting triple-negative breast cancer
    Peter Kirkpatrick
    Nature Reviews Drug Discovery, 2009, 8 : 21 - 21
  • [7] Targeting Triple-Negative Breast Cancer
    Saljoughian, Manouchehr
    US PHARMACIST, 2020, 45 (10) : 6 - 8
  • [8] Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer
    Sethy, Bidyadhar
    Upadhyay, Richa
    Narwanti, Iin
    Yu, Zih-Yao
    Lee, Sung-Bau
    Liou, Jing-Ping
    APOPTOSIS, 2024, 29 (11-12) : 2047 - 2073
  • [9] Identification of dysregulated microRNAs in triple-negative breast cancer
    Yang, Fang
    Zhang, Wenwen
    Shen, Yan
    Guan, Xiaoxiang
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (03) : 927 - 932
  • [10] HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
    Maccallini, Cristina
    Ammazzalorso, Alessandra
    De Filippis, Barbara
    Fantacuzzi, Marialuigia
    Giampietro, Letizia
    Amoroso, Rosa
    PHARMACEUTICALS, 2022, 15 (06)